REGAiN-1A: Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy

Engensis (donaperminogene seltoplasmid) - Beijing Northland, Reyon Pharma, Helixmith

http://clinicaltrials.gov/ct2/show/NCT04469270

Sep 7, 2022